Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

OBJECTIVE: Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and repopulation of different immune cells. Beyond long-term immunologic and clinical data, little is known about acute changes in immunologic and routine laboratory parameters and their clinical relevance durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Katja, Eisele, Judith, Rodriguez-Leal, Francisco Alejandro, Hainke, Undine, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853056/
https://www.ncbi.nlm.nih.gov/pubmed/27213173
http://dx.doi.org/10.1212/NXI.0000000000000228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853056/
https://www.ncbi.nlm.nih.gov/pubmed/27213173
http://dx.doi.org/10.1212/NXI.0000000000000228

Ejemplares similares